DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Sangamo BioSciences, Inc. (SGMO)
« Back to company indexSGMO Chatter Timeline
Stock Ticker for SGMO
Most Active Tweeters for SGMO
| User | Tweets |
|---|---|
| @_B_I_O_T_E_C_H_ | 30 |
| @Gambiste1 | 14 |
| @BiotechAnalysst | 11 |
| @mchilberg | 9 |
| @biotech_junkie | 9 |
Recent Tweets for SGMO
 |
@BigHopeBigWish @_B_I_O_T_E_C_H_ why shit $SGMO big drop today? thx January 17th 2020, 6:01pm |
 |
@Aesculapius1898 RT @_B_I_O_T_E_C_H_: $SGMO the rise of genome editing https://t.co/oxgfpJ8Jep? January 17th 2020, 6:01pm |
 |
@_B_I_O_T_E_C_H_ $SGMO the rise of genome editing https://t.co/oxgfpJ8Jep? January 17th 2020, 6:01pm |
 |
@EVgirl66 RT @JustTradingHoy: $SGMO @sangamoTx did you #FireSandy yet? Again don't send him to another investor conference again. When he goes, h… January 17th 2020, 5:01pm |
 |
@osok762 RT @TomSilver39: WF:" Biotech Management Meetings Reinforce Positive Sector Outlook/Top Picks: $SGMO Key driver: SB-525 Hemophilia A data,… January 17th 2020, 2:01pm |
 |
@JustTradingHoy $SGMO @sangamoTx did you #FireSandy yet? Again don't send him to another investor conference again. When he goe… https://t.co/ucW7XHWbAS January 17th 2020, 1:01pm |
 |
@TranscriptDaily Sangamo Therapeutics $SGMO Upgraded to Strong-Buy by Zacks Investment Research https://t.co/sbTJ9vQssq January 17th 2020, 1:01pm |
 |
@stocknewstimes Sangamo Therapeutics $SGMO Stock Rating Upgraded by Zacks Investment Research https://t.co/GVr3XJAARb January 17th 2020, 1:01pm |
|
@_B_I_O_T_E_C_H_ RT @mchilberg: I'll play a little "what if" . What if $SGMO proves validation of cDNA platform with P I/II data for #Fabry and are able to… January 17th 2020, 1:01pm |
|
@_B_I_O_T_E_C_H_ RT @dteb16: ?READ?THIS?SLOWLY? ???? $SGMO January 17th 2020, 1:01pm |
 |
@mchilberg I'll play a little "what if" . What if $SGMO proves validation of cDNA platform with P I/II data for #Fabry and ar… https://t.co/PceBOnw10I January 17th 2020, 12:01pm |
 |
@MitchellReed09 RT @MaxPowerNGS: @mchilberg Gene therapy is not core for $SGMO. Even if their vector and construct libraries are best in class (which HemoA… January 17th 2020, 11:01am |
 |
@jwil408 RT @TheMarketsDaily: Sangamo Therapeutics $SGMO Stock Rating Upgraded by Zacks Investment Research https://t.co/mDQhfbkex0 January 17th 2020, 11:01am |
 |
@TomSilver39 WF:" Biotech Management Meetings Reinforce Positive Sector Outlook/Top Picks: $SGMO Key driver: SB-525 Hemophilia A… https://t.co/UjXRpMLOyi January 17th 2020, 10:01am |
 |
@ThomasPhilipp6 RT @portefeuillefun: Bought 10k $SGMO at $8.66, now 50k #vssporte shares. January 17th 2020, 10:01am |
 |
@BehaviorFin $8.6 support for $SGMO January 17th 2020, 10:01am |
 |
@portefeuillefun Bought 10k $SGMO at $8.66, now 50k #vssporte shares. January 17th 2020, 10:01am |
 |
@_TJHawkins Does $SGMO sp make sense to anyone????? Other than an opportunity to get a great stock cheaper every day? January 17th 2020, 10:01am |
|
@portefeuillefun Bought 6k $SGMO at $8.85, now 40k #vssporte shares. January 17th 2020, 9:01am |
 |
@Biotech2050 RT @dteb16: So, again, if everyone sadly agrees that $SGMO entire market cap is just HemA SB525 + Cash, and $0 for the rest of the company.… January 17th 2020, 9:01am |
|
@_B_I_O_T_E_C_H_ RT @dteb16: Even slower the third time.... "[FDA]...has been very creative in allowing us [to get to] accelerated approval...” $SGMO January 17th 2020, 9:01am |
 |
@dteb16 So, again, if everyone sadly agrees that $SGMO entire market cap is just HemA SB525 + Cash, and $0 for the rest of… https://t.co/L2yqxaw3BH January 17th 2020, 9:01am |
|
@dteb16 Even slower the third time.... "[FDA]...has been very creative in allowing us [to get to] accelerated approval...” $SGMO January 17th 2020, 9:01am |
|
@dteb16 Repeat this part... “The agency, I think, has been very creative in allowing us to do #accelerated #approval by renal biopsy...” $SGMO January 17th 2020, 9:01am |
|
@dteb16 ?READ?THIS?SLOWLY? ???? $SGMO https://t.co/wNaiwSYMUH January 17th 2020, 9:01am |
|
@_B_I_O_T_E_C_H_ RT @BehaviorFin: This seems to be one of the most important piece of information out of #JPM $SGMO conference. One of the issues on past cl… January 17th 2020, 8:01am |
 |
@Gambiste1 RT @Aesculapius1898: @wyv_123 $sgmo might be an interesting partner for Lilly in Immunology and Neurology January 17th 2020, 6:01am |
 |
@ZolmaxNews Zacks: Analysts Expect Sangamo Therapeutics Inc $SGMO Will Announce Earnings of -$0.31 Per Share https://t.co/ego628tJht January 17th 2020, 5:01am |
 |
@TickerReport -$0.31 Earnings Per Share Expected for Sangamo Therapeutics Inc $SGMO This Quarter https://t.co/cJdvvDjuHw January 17th 2020, 5:01am |
|
@BehaviorFin This seems to be one of the most important piece of information out of #JPM $SGMO conference. One of the issues on… https://t.co/7PaY4rC8oQ January 17th 2020, 5:01am |
 |
@subach $SGMO T-reg program still speculative. Idea of just needing to localize T-regs to tissues specific to disease seems… https://t.co/2EWv9w8SaG January 17th 2020, 4:01am |
|
@subach $SGMO ZFN editing remains in doubt, not dig on the Co! GE is hard, no one has demonstrated it robustly outside of t… https://t.co/awpgcD3OhC January 17th 2020, 4:01am |
 |
@YrbnycC RT @BehaviorFin: How would you rate/consider $SGMO after #JPM presentation yesterday? How would you consider investing in the stock vs $B… January 17th 2020, 3:01am |
|
@BehaviorFin How would you rate/consider $SGMO after #JPM presentation yesterday? How would you consider investing in the stoc… https://t.co/farVPVSnid January 17th 2020, 3:01am |
 |
@vtorion @SangamoTx $sgmo You need to set your roadmap to funding that doesn’t include near term dilution - that’s the big… https://t.co/kaR4LkYgKe January 16th 2020, 6:01pm |
|
@dakotafinancial Sangamo Therapeutics $SGMO Upgraded to “Strong-Buy” by Zacks Investment Research https://t.co/2mZ6EbTcqy January 16th 2020, 5:01pm |
 |
@TheMarketsDaily Sangamo Therapeutics $SGMO Stock Rating Upgraded by Zacks Investment Research https://t.co/mDQhfbkex0 January 16th 2020, 5:01pm |
|
@Gambiste1 RT @mchilberg: Commented on $SGMO - Sangamo 2020: Gene Therapy Plus Optionality Equals Opportunity. https://t.co/SRC3Hw4iyg January 16th 2020, 5:01pm |
|
@mchilberg Commented on $SGMO - Sangamo 2020: Gene Therapy Plus Optionality Equals Opportunity. https://t.co/SRC3Hw4iyg January 16th 2020, 5:01pm |
 |
@heyjt55 RT @yusufhameed: $SGMO at #JPM2020 was pretty solid. All the money coming into Sangamo bank account from Pfizer in 2020 is impressive, can'… January 16th 2020, 4:01pm |
 |
@yusufhameed $SGMO at #JPM2020 was pretty solid. All the money coming into Sangamo bank account from Pfizer in 2020 is impressiv… https://t.co/0qhy31B0hs January 16th 2020, 4:01pm |
 |
@ChartMill $SGMO has a Current Ratio of 4.77, so it is financially healthy and has no problem in meeting its obligations.… https://t.co/HheIVbKcmp January 16th 2020, 4:01pm |
|
@_B_I_O_T_E_C_H_ RT @_B_I_O_T_E_C_H_: $SGMO Hemophilia A " program alone is worth more than the market cap " #JPM20 https://t.co/9Cyw1V9uQZ January 16th 2020, 4:01pm |
 |
@YMuer RT @_B_I_O_T_E_C_H_: $SGMO JPMorgan Breakout Session: Patient 9 factor levels are recovering ! #JPM20 https://t.co/IIoXyPRiRu January 16th 2020, 3:01pm |
 |
@BiotechAnalysst RT @mchilberg: Interesting to hear $SGMO say they would be done with #Genetherapy after PKU when they showed discovery activity just 3 wks… January 16th 2020, 3:01pm |
|
@BiotechAnalysst RT @_B_I_O_T_E_C_H_: $SGMO talking #AA on #Fabry with a creative #FDA " The agency, I think, has been very creative in allowing us to do #… January 16th 2020, 3:01pm |
|
@BiotechAnalysst RT @_B_I_O_T_E_C_H_: JPMorgan Breakout Session $SGMO #FABRY "per discussions with the #FDA, 6-month Gb3 kidney levels assessed by biopsy i… January 16th 2020, 3:01pm |
|
@BiotechAnalysst RT @_B_I_O_T_E_C_H_: $SGMO CEO says "We get $300 million between the IND transfer and the first commercial patient. And then we get betwee… January 16th 2020, 3:01pm |
|
@_B_I_O_T_E_C_H_ $SGMO talking #AA on #Fabry with a creative #FDA " The agency, I think, has been very creative in allowing us to d… https://t.co/JKtHDrg1VT January 16th 2020, 3:01pm |
|
@_B_I_O_T_E_C_H_ JPMorgan Breakout Session $SGMO #FABRY "per discussions with the #FDA, 6-month Gb3 kidney levels assessed by biops… https://t.co/ZqFJtQvlVF January 16th 2020, 3:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.